0000125/2024 Framework Agreement With A Single Company, Which Establishes The Conditions For The Supply Of The Successive Tract Of The Exclusive Medicinal Product Named Tecartus (Brexucabtagen Autoleucel), For The Pharmacy Service Of The Regional University Hospital Of Málaga, Provincial Purchasing Central Of Málaga, Through A Negotiated Procedure Without Advertising. Cca.: +6.C3I7Xus

SERVICIO ANDALUZ DE SALUD Spain has Released a tender for 0000125/2024 Framework Agreement With A Single Company, Which Establishes The Conditions For The Supply Of The Successive Tract Of The Exclusive Medicinal Product Named Tecartus (Brexucabtagen Autoleucel), For The Pharmacy Service Of The Regional University Hospital Of Málaga, Provincial Purchasing Central Of Málaga, Through A Negotiated Procedure Without Advertising. Cca.: +6.C3I7Xus in Pharmaceuticals. The tender was released on Apr 08, 2024.

Country - Spain

Summary - 0000125/2024 Framework Agreement With A Single Company, Which Establishes The Conditions For The Supply Of The Successive Tract Of The Exclusive Medicinal Product Named Tecartus (Brexucabtagen Autoleucel), For The Pharmacy Service Of The Regional University Hospital Of Málaga, Provincial Purchasing Central Of Málaga, Through A Negotiated Procedure Without Advertising. Cca.: +6.C3I7Xus

Deadline - login to view

GT reference number - 80608566

Product classification - Pharmaceutical products